DFCI IN 2024.

Dr. Jennifer Ligibel will be presenting new research on exercise to increase treatment efficacy and reduce toxicity in early #BreastCancer in today's #AACR24 Major Symposium on Interventional Studies During Cancer Treatment to Improve Symptoms & Outcomes
abstractsonline.com/pp8/#!/20272/s…

Check out the latest #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (April 1st-7th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancer Research

Results of the Phase II #PACEStudy : Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- #MetastaticBreastCancer were presented at #AACR24 . Erica Mayer Meredith Regan, ScD Sara Tolaney Rinath Jeselsohn Massimo Cristofanilli, MD, FACP Lorenzo Gerratana
abstractsonline.com/pp8/#!/20272/p…

#ClinicalMedicine :
HER2 heterogeneity and treatment response–associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial: buff.ly/4cJYFXT

Polyak Lab Otto Metzger Dana-Farber Yale School of Medicine
#Oncology

Have you read this excellent JAMA Oncology review on #PARPInhibitors for #BreastCancer Treatment?
If not, here is the link 👇👇👇pubmed.ncbi.nlm.nih.gov/38512229/
Stefania Morganti, MD Carmen Criscitiello Filipa Lynce, MD, FASCO Antonio Giordano, MD PhD Antonio Marra Carmine De Angelis G Curigliano MD PhD judy garber Giampaolo Bianchini Angela Toss

Finally have our high quality lab picture at Dana-Farber Cancer Biology Department retreat. We are excited to have our very first graduate student Orville from Harvard Chemistry, and our new lab technician Anna joined us. Hopefully, we will have all our members in the pic next time Dana-Farber Chemical Biology Program.

Our lab enjoyed eclipse from the Quad 🤩

Harvard Medical School Dana-Farber Kathleen Helen Burns Namrata Singh, PhD #corelab #Eclipse2024 #EclipseSolar2024

Dana-Farber’s Breast Oncology Center (Dana-Farber’s Breast Oncology Center) is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH

oncodaily.com/44829.html

#oncodaily #oncology #cancer #BreastCancerResearch #HER2Positive #OncologyTrials #Phase2Trial

Headshot at AACR24 #aacr 24 #aacr #CancerResearch #dfci #harvardmedicalschool AACR AACRFoundation

Congratulations Franziska Wachter in Fischer Lab for receiving the 2024 Sidney Farber Scholar Award!!

Wonderful results using Nucei AI and Threshold Annotation from Visiopharm on my Phenocycler Fusion Florescence image🤩

Kathleen Helen Burns Namrata Singh, PhD #AI #Immuneoncology #cancerresearch #spatialbiology #corelab Massachusetts Life Sciences Center

Thank you for featuring our work! Yuzhen Zhou Vince D’Andrea, MD Raie Bekele Filipe LF Carvalho joaquim bellmunt Brigham and Women’s Radiation Oncology Dana-Farber Lank Center for Genitourinary Oncology

Join Dr. Kornelia Polyak (Polyak Lab) on April 6th as she discusses drivers of age-related increase in breast #tumorigenesis in a plenary session on Discovery Science in Early Cancer Biology and Interception at #AACR24 . #BreastCancer #bcsm

Day1 at AACR2024!! Fantastic educational sessions on usage of inhibitors and target validation approaches , PROTACs and patient derived organoids.. can’t wait for tomorrow’s sessions!! #AACR24 #aacr AACR AACRFoundation #SanDiego #dfci Dana-Farber Harvard Medical School !!
M

Join Dr. Jennifer Guerriero (@jennguerriero) Sun April 7th for her presentation on leveraging the complexities of tumor associated macrophages for effective anti-cancer therapy.
Check out the #AACR24 abstract here:
abstractsonline.com/pp8/#!/20272/p…

Don't miss Adam Nelson, Ph.D. sharing his research on PARP1 selective inhibitor DSB1559 efficacy in BRCA1-associated #TNBC at today's #AACR24 poster session on DNA damage and repair. @jennguerriero
abstractsonline.com/pp8/#!/20272/p…

Congratulations to my former Broadie and DFCI colleagues for their induction as 2024 ⁦AACR⁩ Fellows #AACR24 ⁦Broad Institute⁩ ⁦Dana-Farber⁩ . Well deserved.

Dr. Jose Pablo Leone commented on CURE Today about Long-Term Breast Cancer Mortality Risk in Men. #MaleBreastCancer
#BreastCancerInMen

Read the full article here 👇curetoday.com/view/breast-ca…

Second talk of the session is given by Lyn Jones (@DFCI_ChemBio), spanning Cereblon molecular glues and next-gen covalent drug discovery.
#MedChemFrontiers24
EFMC
ACS Division of Medicinal Chemistry